A. Mahiout et al., ADVANCED GLYCATION END-PRODUCTS IN THE PERITONEAL-FLUID AND IN THE PERITONEAL MEMBRANE OF CONTINUOUS AMBULANT PERITONEAL-DIALYSIS PATIENTS, Nephrology, dialysis, transplantation, 11, 1996, pp. 2-6
In patients on continuous ambulant peritoneal dialysis (CAPD) treatmen
t, the peritoneal membrane is continuously exposed to the high glucose
concentration contained in the dialysate. This may lead to the local
generation of advanced glycation end-products (AGEs). To test this hyp
othesis we evaluated the plasma and dialysate AGE concentrations in fi
ve CAPD patients. The dialysate was measured after a 1 h and after a 1
2 h dwell time. Additionally, in two patients an immunohistochemical i
nvestigation of the peritoneal membrane for AGE was performed. For the
determination of AGE an ELISA using a polyclonal antibody against AGE
bovine serum albumin was used; the immunohistochemical staining was p
erformed using the streptavidin-biotin complex method. We found only l
ow concentrations of AGE in the dialysate after a 1 h dwell time; afte
r 12 h, however, the dialysate AGE was even greater than the plasma co
ncentration. In both peritoneal specimens we found positive staining f
or AGE in the interstitium of the mesothelial layer. The dialysate AGE
contained a high proportion of high-molecular-weight AGE proteins, an
d low-molecular-weight AGE was found to be in the same concentration r
ange as the total serum ACE. We conclude that there is local generatio
n of AGE in the peritoneal membrane and a 'washing out' of AGE from th
e peritoneal membrane during longer dwell times. We speculate that the
accumulation of AGE might lead to some of the functional and morpholo
gical alterations observed after long-term CAPD.